COMMUNIQUÉS West-GlobeNewswire

Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference

08/01/2025 - 22:05

FOSTER CITY, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product [...]

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

08/01/2025 - 22:05

Preliminary unaudited revenue expected to be between $21.0 million and $21.5 million for Q4 2024, and between $79.4 million and $79.9 million for full year 2024 Scott Huennekens Appointed to NeuroPace Board of Directors [...]

Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026

08/01/2025 - 22:05

Investigational new drug (IND) applications for initiating first-in-human studies for ZW220 and ZW251 in solid tumors anticipated in 2025 IND applications for initiating first-in-human studies for ZW209 and ZW1528 [...]

Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

08/01/2025 - 22:05

SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation [...]

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET

08/01/2025 - 22:05

WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing innovative life-transforming therapeutics for people living [...]

Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue

08/01/2025 - 22:10

Announces Earnings Release Date SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and [...]

NurExone Biologic Secures Master Cell Bank

08/01/2025 - 22:12

A Key Milestone for Therapeutic Exosome Production TORONTO and HAIFA, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (" NurExone " or the " Company "), a [...]

FluidForm Bio™ Announces Participation at Biotech Showcase and the 14th Annual LifeSci Partners Corporate Access Event

08/01/2025 - 22:12

WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced that Mike Graffeo, CEO and co-founder, will deliver a company [...]

Cognition Therapeutics CEO Participating in Longwood and Sachs Conferences

08/01/2025 - 22:14

PURCHASE, N.Y., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced [...]

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch

08/01/2025 - 22:15

-- Approximately $50.0 million of net revenue from sales of LUMRYZ™ estimated for the fourth quarter, a greater than 150% increase over $19.5 million for the comparable period in 2023 -- --2,500 patients on LUMRYZ as of [...]

Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

08/01/2025 - 22:15

MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what [...]

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

08/01/2025 - 22:30

AUDUBON, Pa., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year [...]

Monthly information on share capital and company voting rights

08/01/2025 - 22:30

(Article 223-16 of General Regulation of the French financial markets authority) PARIS, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

08/01/2025 - 22:30

(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 08 janv. 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]

DiagnaMed Announces Resignation of Director and Grant of Stock Options

08/01/2025 - 23:00

TORONTO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF) announces that Elyssia Patterson has resigned from the board. The Company also announces that [...]

Nova Leap Health Corp. Announces Results of Special Meeting of Shareholders

08/01/2025 - 23:01

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Jan. 08, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”) is [...]

Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference

08/01/2025 - 23:13

BOSTON and SOUTH SAN FRANCISCO, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation (“Frontier” or the “Company”), a clinical-stage precision medicine company unlocking to advance transformational [...]

Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand

08/01/2025 - 23:15

Avid Urges Stockholders to Vote FOR the Pending Transaction TODAY TUSTIN, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract [...]

Now Open: VITAS® Healthcare Inpatient Hospice Unit in Fort Worth

08/01/2025 - 14:14

Freestanding homelike facility for specialized end-of-life care will serve 500+ patients annually FORT WORTH, Texas, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Easier access to compassionate end-of-life care is now available for [...]